Curamir Therapeutics, a cancer therapeutics developer exploiting Suny research into microRNA, has made its formal debut with $10m of series A funding.

KDDI, Mitsui Fudosan, Banco Santander, Mitsubishi UFJ and Nomura are among the investors that have provided $14m in a series A extension round, taking the round to $26.5m.

Xinyi Biotech and Legend Star helped supply xenotransplantation technology startup Qihan Biotech with $25.5m to follow $7.8m raised last year.

Cash Capital co-led a series A for Vision Medicals, co-founded by faculty at the Yunnan Province Key Laboratory for Gene Editing.

Moti has received funding from SIG Asia to close its series A round following a $31m first tranche in July.

Boundless Bio, which is developing treatments focusing on extrachromosomal DNA, has raised $46.4m from investors including Alexandria Venture Investments.

The granular data platform raised the money in a series A round led by strategic investor US Ecology that boosted its overall funding to more than $26m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The farming robotics developer increased its overall funding to more than $20m in a $14.5m round featuring Wilbur Ellis.

Automated driving systems manufacturer CalmCar collected $14m from a SAIC Motor subsidiary and Beijing Connected Vehicles Development Fund having previously been backed by BAIC and China Unicom among others.